BMY.SW Bristol-Myers Squibb (SIX) -4.40% 17 Mar 2026: oversold bounce

We saw BMY.SW stock close at CHF 42.54 on 17 Mar 2026, down -4.40%, creating a potential oversold bounce setup for short-term traders. Volume was 500 shares with a relative volume of 22.73, signaling unusually active trading at the day low and year low of CHF 42.54. We lay out the technical trigger, valuation context, Meyka AI grade and a clear trade plan tied to the April earnings calendar and sector trends.

BMY.SW stock technical snapshot

Price action closed at CHF 42.54, below the 50/200-day averages of CHF 43.75, and matched the year low of CHF 42.54. One clear technical fact: the stock fell -4.40% on low absolute volume but very high relative volume, which often precedes short-term mean reversion.

Momentum reads are mixed. MACD sits at -0.11 and ADX at 100.00, indicating a strong directional move. Keltner lower band is CHF 42.59, putting current price inside the lower channel and flagging a bounce candidate.

Why today’s drop matters and sector context

The Healthcare sector has been softer year to date, and drug-makers show mild weakness versus defensive peers. BMY.SW’s drop to the CHF 42.54 pivot matters because it tests multiple supports at the year low and short-term moving averages.

Investors should watch broader drug-maker flows and major Swiss healthcare peers for correlation. For sector reference see recent coverage on major pharma moves from Bloomberg and MarketBeat sources source source.

Fundamentals and valuation for Bristol-Myers Squibb (BMY.SW)

Bristol-Myers Squibb shows solid cash generation and a conservative payout. Key fundamentals: EPS CHF 2.69, PE 15.81, market cap CHF 70.70B, dividend yield 3.50%, and payout ratio 0.73. Free cash flow yield is strong at 22.96%, supporting the dividend and buyback optionality.

Risks are concentrated in leverage metrics. Debt-to-equity is 2.75, and net-debt-to-EBITDA is near 3.00, leaving less balance-sheet flexibility than lower-levered peers. These factors explain mixed valuation despite healthy margins.

Technical setup: oversold bounce case and trade triggers

We frame an oversold bounce strategy: entry on a clear reversal candle above intraday resistance near CHF 43.00, with a tighter stop below today’s low at CHF 42.30. Target one near CHF 46.00 and target two near CHF 52.00 for a staged exit if momentum returns.

Confirmation should come from a positive MACD crossover and rising volume. A failure to reclaim CHF 43.75 (50/200-day average) would invalidate the bounce and shift the bias to further downside.

Meyka AI grade, forecast and price targets

Meyka AI rates BMY.SW with a score out of 100: 73.72 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Meyka AI’s forecast model projects a 1-year price of CHF 39.34, implying -7.53% versus the current CHF 42.54. For practical trading we list realistic targets: conservative rebound CHF 46.00 (+8.13%), bullish target CHF 52.00 (+22.25%), and downside risk CHF 38.00 (-10.67%). Forecasts are model-based projections and not guarantees.

Trading plan and key risks

For the oversold bounce strategy we recommend small, staged positions. Use tight risk: initial stop around CHF 42.30 and position-size to limit loss to 1.0%–2.0% of portfolio capital. Take partial profits at CHF 46.00.

Key risks include a negative earnings surprise on the scheduled announcement 30 Apr 2026, sector-wide selling, and sustained high leverage. Monitor intraday liquidity—the average volume is low at 22 shares historically, so execution risk exists on SIX.

Final Thoughts

BMY.SW stock sits at a technical inflection after a -4.40% drop to CHF 42.54, creating a defined oversold bounce opportunity for short-term traders. Valuation is mixed: a fair P/E near 15.81, strong free cash flow yield of 22.96%, but elevated debt metrics. Meyka AI rates the stock 73.72 (B+) and projects CHF 39.34 for a one-year model target, implying -7.53% from today’s close. That forecast highlights asymmetric outcomes: a measured bounce toward CHF 46.00 offers a clear reward-to-risk for disciplined trades, while failure to hold CHF 42.30 opens room to the CHF 38.00 downside. We recommend watching a volume-backed reversal and the April 30 earnings date before adding significant exposure. Use tight stops, staged sizing, and the sector flow as a confirmation source. See the Meyka AI stock page for live updates and execution tools: BMY.SW on Meyka.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.